Click to close

Contact us

Please complete the required fields.

*Required Fields

Send
Click to close

Request a Demo

Please complete the required fields.

*Required Fields

Request a Demo
Click to close

Report Problem

Please complete the required fields.

*Required Fields

Send

Login

Click to close

Please complete the required fields.

Forgot your password? Register

Tell us your email address and we'll send you instructions on how to reset your password.

Click to close

Resolution not supported

Click to close

Saving...

Resolution not supported

  • Glossary

The following are our definitions of relevant industry terminology with special focus on our analytics and visualizations.

  • Research Center: These medical facilities represent the physical hospitals, medical clinics, individual practices, or dedicated research organizations that are partially or fully focused on clinical research. Research centers may have one or more clinical teams, usually focused on specific diseases or therapeutic areas (e.g. Oncology or Infectious Diseases) and may house several sites.

  • Site: different from research centers, sites are comprised of a dedicated team and infrastructure focused on a specific clinical trial. Bigger Research Centers (e.g., hospitals) often have multiple concurrent sites within their facilities (departments and sub-departments) which are dedicated to specific diseases.. For smaller Research Centers it is often the case that center is equal to site, as they participate with the same team and facility in different clinical trials.

  • Patient Population: individuals suffering from a specific disease within a defined geographic area. It is possible to search for availability of patients and their level of engagement in clinical trials.

    • Enrolled Patients: calculated number of individuals who have been enrolled in clinical trials for a specific disease in a given location in the last five years. The calculation is based on the contributions of individual research centers in a given location.

    • Available Patients: calculated number of individuals suffering from a specific disease in a given location who may be considered for enrollment in clinical trials. This information is derived from epidemiological and demographic data.

    • Available Patients per Trials at Site Level: number of ‘Available Patients’ for a specific disease per trials at site level (number of sites that have been initiated for trials in a specific disease) in a given location in the last five years.

    • Available Patients per Centers: number of ‘Available Patients’ for a specific disease per research center in a given location.

    • Engagement Level: number of ‘Enrolled Patients’ per 100,000 ‘Available Patients’ in a given location.

    • Available Patients & Patient Engagement Level: ‘Available Patients’ per disease and their respective engagement in clinical trials. The number of ‘Available Patients’ is represented by the size of the diamonds; bigger diamonds indicate a higher number of ‘Available Patients’. Patient engagement is represented by the number of ‘Enrolled Patients’ per 100,000 ‘Available Patients’ in a given location. Deep green diamonds indicate high ‘Patient Engagement Levels’ in a region, light green diamonds indicate low ‘Patient Engagement Levels’.

  • Research Activity: engagement of research centers in clinical trials according to ClinicalTrials.gov. It is possible to search for specific diseases and different phases of clinical trials, including activity growth trends in a given location.

    • Trials at Site Level (All Phases): Number of sites that have been initiated for trials in a specific disease in a given location in the last five years.

    • Trials at Site Level (Phases I, II, III and IV): Number of sites that have been initiated for phase I, II, III or IV trials in a specific disease in a given location in the last five years. It is possible to search for different phases.

    • Trials at Site Level (ongoing): number of sites which have been initiated in ongoing trials for a specific disease in a given location in the last five years.

    • Trials at Site Level & Growth Rate: Number of sites that have been initiated for trials in a specific disease in a given location and its growth rate in the last five years. The number of ‘Trials at Site Level’ is represented by the size of the diamonds; bigger diamonds indicate a higher number of trials at site level in a given location. Positive growth rates are shown as green diamonds in the platform, and indicate increasing participation of research centers in clinical trials in a given location. Negative growth rates are shown as red diamonds, and indicate decreasing participation of research centers in clinical trials in a given location.

  • Research Infrastructure: list and number of research centers available in a given location, and their capabilities represented by the number of different diseases studied and clinical trials initiated. It is possible to search for the number of different diseases studied, and the number of clinical trials initiated per center in a given location in the last 5 years.

    • Centers: number of research centers initiated in clinical trials in a given location. It is possible to search for specific diseases and locations.

    • Centers & Trials per Center: number of research centers and number of clinical trials initiated per center for a specific disease in a given location. The number of research centers is represented by the size of the diamonds. Bigger diamonds indicate a higher number of research centers in a given location. Deep green diamonds indicate a high number of trials per center in a given location, light green diamonds indicate a low number of trials per center in a given location.

    • Preference Level: percentage of the total number of clinical trials initiated for a specific disease in a given location.

  • Research Team: number of investigators participating in clinical trials for all or specific diseases in a given location.